Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8

Liver gene transfer with adeno-associated viral (AAV) 2/8 vectors is being considered for therapy of systemic diseases like mucopolysaccharidosis type VI (MPS VI), a lysosomal storage disease due to deficiency of arylsulfatase B (ARSB). We have previously reported that liver gene transfer with AAV2/...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ferla, Rita, O'Malley, Thomas, Calcedo, Roberto, O'Donnell, Patricia, Wang, Ping, Cotugno, Gabriella, Claudiani, Pamela, Wilson, James M., Haskins, Mark, Auricchio, Alberto
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2013
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581049/
https://ncbi.nlm.nih.gov/pubmed/23194248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2012.179
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki